Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Chinese Clinical Research Plan for the Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

NCT06606509 is registered in ClinicalTrials.gov with Nanjing First Hospital, Nanjing Medical University as lead sponsor.

NCT NCT06606509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06606509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Chinese Clinical Research Plan for the Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).
Lead sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
November 7, 2024
Completion date
June 30, 2027
Enrollment
1,000 (estimated)
Sites
101

Conditions

As the registry lists them; a condition with its own page is linked.

type1 diabetes mellitus